Waterwort D M, Bassett A S, Brzustowicz L M
Department of Genetics, Rutgers University, Piscataway, New Jersey 08854-8082, USA.
Cell Mol Life Sci. 2002 Feb;59(2):331-48. doi: 10.1007/s00018-002-8426-6.
The genetic etiology of schizophrenia, a common and debilitating psychiatric disorder, is supported by a wealth of data. Review of the current findings suggests that considerable progress has been made in recent years, with a number of chromosomal regions consistently implicated by linkage analysis. Three groups have shown linkage to 1q21-22 using similar models, with HLOD scores of 6.5, 3.2, and 2.4. Other replicated loci include 13q32 that has been implicated by two independent groups with significant HLOD scores (4.42) or NPL values (4.18), and 5pl4.1-13.1, 5q21-33, 8p2l-22, and 10p11-15, each of which have been reported as suggestive by at least three separate groups. Different studies have also replicated evidence for a modest number of candidate genes that were not ascertained through linkage. Of these, the greatest support exists for the DRD3 (3q13.3), HTR2A (13q14.2), and CHRNA7 (15q13-q14) genes. The refinement of phenotypes, the use of endophenotypes, reduction of heterogeneity, and extensive genetic mapping have all contributed to this progress. The rapid expansion of information from the human genome project will likely further accelerate this progress and assist in the discovery of susceptibility genes for schizophrenia. A greater understanding of disease mechanisms and the application of pharmacogenetics should also lead to improvements in therapeutic interventions.
精神分裂症是一种常见且使人衰弱的精神疾病,大量数据支持了其遗传病因。对当前研究结果的回顾表明,近年来已取得了相当大的进展,一些染色体区域通过连锁分析一直被牵连其中。三个研究小组使用相似模型显示与1q21 - 22存在连锁,最高似然比统计值(HLOD)分数分别为6.5、3.2和2.4。其他重复验证的位点包括13q32,两个独立研究小组发现其与显著的HLOD分数(4.42)或非参数连锁(NPL)值(4.18)相关;还有5pl4.1 - 13.1、5q21 - 33、8p2l - 22和10p11 - 15,每个位点都至少被三个独立研究小组报告为有提示意义。不同研究还重复验证了一些并非通过连锁分析确定的少量候选基因的证据。其中,对DRD3(3q13.3)、HTR2A(13q14.2)和CHRNA7(15q13 - q14)基因的支持力度最大。表型的细化、内表型的使用、异质性的降低以及广泛的基因定位都促成了这一进展。人类基因组计划信息的迅速扩展可能会进一步加速这一进展,并有助于发现精神分裂症的易感基因。对疾病机制更深入的理解以及药物遗传学的应用也应会带来治疗干预方面的改进。